Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-14 1:49 pm Purchase | 2024-12-31 | 13G | Avid Bioservices, Inc. CDMO | AltraVue Capital, LLC | 3,797,813 5.900% | 438,481 (+13.05%) | Filing History |
| 2024-12-13 10:53 am Purchase | 2024-12-09 | 13G | Avid Bioservices, Inc. CDMO | Glazer Capital, LLC | 3,394,114 5.310% | 3,394,114 (New Position) | Filing History |
| 2024-11-14 7:53 pm Purchase | 2024-09-30 | 13G | Avid Bioservices, Inc. CDMO | Point72 Asset Management, L.P. | 5,282,640 8.300% | 2,056,634 (+63.75%) | Filing History |
| 2024-11-12 4:15 pm Sale | 2024-11-07 | 13G | Avid Bioservices, Inc. CDMO | Integrated Core Strategies (US) LLC | 880,968 1.400% | -3,359,179 (-79.22%) | Filing History |
| 2024-10-17 11:42 am Sale | 2024-09-30 | 13G | Avid Bioservices, Inc. CDMO | STATE STREET CORP STT | 3,002,503 4.700% | -1,781,736 (-37.24%) | Filing History |
| 2024-04-26 4:15 pm Purchase | 2024-04-25 | 13G | Avid Bioservices, Inc. CDMO | Point72 Asset Management, L.P. | 3,226,006 5.100% | 3,226,006 (New Position) | Filing History |
| 2024-04-17 7:05 pm Purchase | 2024-04-15 | 13G | Avid Bioservices, Inc. CDMO | AltraVue Capital, LLC | 3,359,332 5.300% | 384,999 (+12.94%) | Filing History |
| 2024-02-14 10:04 am Purchase | 2023-12-31 | 13G | Avid Bioservices, Inc. CDMO | T. Rowe Price Investment Management, Inc. | 4,352,252 6.900% | 744,599 (+20.64%) | Filing History |
| 2024-02-13 4:59 pm Sale | 2023-12-29 | 13G | Avid Bioservices, Inc. CDMO | The Vanguard Group | 3,617,873 5.720% | -731,417 (-16.82%) | Filing History |
| 2024-01-26 4:57 pm Sale | 2023-12-31 | 13G | Avid Bioservices, Inc. CDMO | AltraVue Capital, LLC | 2,974,333 4.700% | -328,627 (-9.95%) | Filing History |
| 2024-01-25 08:41 am Sale | 2023-12-31 | 13G | Avid Bioservices, Inc. CDMO | STATE STREET CORP STT | 4,784,239 7.570% | -339,567 (-6.63%) | Filing History |
| 2024-01-08 4:35 pm Sale | 2023-12-31 | 13G | Avid Bioservices, Inc. CDMO | BlackRock Inc. BLK | 5,281,444 8.400% | -4,636,659 (-46.75%) | Filing History |
| 2024-01-08 4:32 pm Sale | 2023-12-31 | 13G | Avid Bioservices, Inc. CDMO | Integrated Core Strategies (US) LLC | 4,240,147 6.700% | -354,880 (-7.72%) | Filing History |
| 2023-12-19 4:05 pm Purchase | 2023-12-12 | 13G | Avid Bioservices, Inc. CDMO | Integrated Core Strategies (US) LLC | 4,595,027 7.300% | 3,943,316 (+605.07%) | Filing History |
| 2023-02-14 12:40 pm Purchase | 2022-12-31 | 13G | Avid Bioservices, Inc. CDMO | T. Rowe Price Investment Management, Inc. | 3,607,653 5.800% | 3,607,653 (New Position) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Avid Bioservices, Inc. CDMO | The Vanguard Group | 4,349,290 6.980% | 338,574 (+8.44%) | Filing History |
| 2023-02-09 10:43 am Purchase | 2022-12-31 | 13G | Avid Bioservices, Inc. CDMO | STATE STREET CORP STT | 5,123,806 8.220% | 1,398,668 (+37.55%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Avid Bioservices, Inc. CDMO | BlackRock Inc. BLK | 9,918,103 15.900% | 0 (Unchanged) | Filing History |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | Avid Bioservices, Inc. CDMO | BlackRock Inc. BLK | 9,918,103 15.900% | 248,325 (+2.57%) | Filing History |
| 2023-01-18 8:03 pm Purchase | 2022-12-31 | 13G | Avid Bioservices, Inc. CDMO | AltraVue Capital, LLC | 3,302,960 5.300% | 192,660 (+6.19%) | Filing History |